Inventor
CHITTENDEN THOMAS
US15 patents
⚠️ This page may combine multiple inventors who share the name “CHITTENDEN THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNOGEN INC
10 patentsUS10077313B2Sep 18, 2018
Anti-CD123 antibodies and conjugates and derivatives thereof
IMMUNOGEN INC12 citations92
US7202346B2Apr 10, 2007
Antibodies to non-shed Muc1 and Muc16, and uses thereof
IMMUNOGEN INC62 citations92
US10919969B2Feb 16, 2021
Anti-CD123 antibodies and conjugates and derivatives thereof
IMMUNOGEN INC4 citations83
US10442865B2Oct 15, 2019
Methods of use of anti-CD123 antibodies and antigen-binding fragments thereof
IMMUNOGEN INC4 citations83
US11834498B2Dec 5, 2023
Biparatopic FR-alpha antibodies and immunoconjugates
IMMUNOGEN INC2 citations72
US11332535B2May 17, 2022
Anti-CD123 antibodies and conjugates and derivatives thereof
IMMUNOGEN INC2 citations72
US10875925B2Dec 29, 2020
Anti-CD123 antibodies and conjugates and derivatives thereof
IMMUNOGEN INC3 citations72
US11897961B2Feb 13, 2024
Anti-CD123 antibodies and conjugates and derivatives thereof
IMMUNOGEN INC0 citations62
US9125896B2Sep 8, 2015
EGFR-binding molecules and immunoconjugates thereof
IMMUNOGEN INC3 citations62
US7202024B2Apr 10, 2007
bbc3 Gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
IMMUNOGEN INC1 citations45
SETIADY JULIANTO
3 patentsUS8790649B2Jul 29, 2014
EGFR-binding molecules and immunoconjugates thereof
SETIADY JULIANTO26 citations90
US9233171B2Jan 12, 2016
Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate
SETIADY JULIANTO4 citations71
US9238690B2Jan 19, 2016
Non-antagonistic EGFR-binding molecules and immunoconjugates thereof
SETIADY JULIANTO1 citations50